At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Factors that influence compliancebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis
University of Texas Southwestern Medical Center·observational·Posted Sep 22, 2005·Updated Jan 25, 2007
In Brief
An observational study evaluating Factors that influence compliance for Multiple Sclerosis. Completed, across 1 site.
Detailed Summary
The purpose of this study is to evaluate the coorelation between patient factors, health care provider factors, drug factors and compliance in patients with relapsing forms of multiple sclerosis (RMS) treated with Disease Modifying Agents (DMA). We hypothesize that a number of factors influence compliance with DMA's.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
CollaboratorsBiogen
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2004
Study CompletionSep 2005
First PostedSep 2005
TodayJul 2026
First PostedSep 22, 2005
Enrollment StartApr 1, 2004
Study CompletionSep 1, 2005
TodayJul 2, 2026
Posted 20.8 years ago
Interventions
Factors that influence compliancebehavioral